BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25203494)

  • 21. Pap smear screening, pap smear abnormalities and psychosocial risk factors among women in a residential alcohol and drug rehabilitation facility.
    Soccio J; Brown M; Comino E; Friesen E
    J Adv Nurs; 2015 Dec; 71(12):2858-66. PubMed ID: 26279461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cervical cancer risk as a predictor of Pap smear use in rural North Carolina.
    Cyrus-David MS; Michielutte R; Paskett ED; D'Agostino R; Goff D
    J Rural Health; 2002; 18(1):67-76. PubMed ID: 12043757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The frequency of Pap smear screening in the United States.
    Sirovich BE; Welch HG
    J Gen Intern Med; 2004 Mar; 19(3):243-50. PubMed ID: 15009779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knowledge, attitudes, and practices toward cervical cancer prevention among women in Kampong Speu Province, Cambodia.
    Touch S; Oh JK
    BMC Cancer; 2018 Mar; 18(1):294. PubMed ID: 29544466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Women's Behaviors Toward Mammogram and Pap Test: Opportunities to Increase Cervical Cancer Screening Participation Rates among Older Women.
    Tavasoli SM; Kane E; Chiarelli AM; Kupets R
    Womens Health Issues; 2018; 28(1):42-50. PubMed ID: 29174212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in Breast and Cervical Cancer Screening Rates in Jordan among Women from Different Socioeconomic Strata: Analysis of the 2012 Population-Based Household Survey.
    Al Rifai R; Nakamura K
    Asian Pac J Cancer Prev; 2015; 16(15):6697-704. PubMed ID: 26434897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal Pap smear follow-up in a high-risk population.
    Engelstad LP; Stewart SL; Nguyen BH; Bedeian KL; Rubin MM; Pasick RJ; Hiatt RA
    Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1015-20. PubMed ID: 11588126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attitudes and factors affecting acceptability of self-administered cervicovaginal sampling for human papillomavirus (HPV) genotyping as an alternative to Pap testing among multiethnic Malaysian women.
    Ma'som M; Bhoo-Pathy N; Nasir NH; Bellinson J; Subramaniam S; Ma Y; Yap SH; Goh PP; Gravitt P; Woo YL
    BMJ Open; 2016 Aug; 6(8):e011022. PubMed ID: 27491667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sociodemographic factors associated with cervical cancer screening and follow-up of abnormal results.
    Elit L; Krzyzanowska M; Saskin R; Barbera L; Razzaq A; Lofters A; Yeritsyan N; Bierman A
    Can Fam Physician; 2012 Jan; 58(1):e22-31. PubMed ID: 22267636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
    Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
    Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors associated with receiving Pap tests among married immigrant women of Vietnamese origin in southern Taiwan.
    Lee FH; Wang HH; Tsai HM; Lin ML
    Women Health; 2016; 56(3):243-56. PubMed ID: 26362802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of Potentially Unnecessary Bimanual Pelvic Examinations and Papanicolaou Tests Among Adolescent Girls and Young Women Aged 15-20 Years in the United States.
    Qin J; Saraiya M; Martinez G; Sawaya GF
    JAMA Intern Med; 2020 Feb; 180(2):274-280. PubMed ID: 31904768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening mammography and Pap tests among older American women 1996-2000: results from the Health and Retirement Study (HRS) and Asset and Health Dynamics Among the Oldest Old (AHEAD).
    Ostbye T; Greenberg GN; Taylor DH; Lee AM
    Ann Fam Med; 2003; 1(4):209-17. PubMed ID: 15055410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast and cervical cancer screening in obese minority women.
    Ferrante JM; Chen PH; Jacobs A
    J Womens Health (Larchmt); 2006 Jun; 15(5):531-41. PubMed ID: 16796480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cervical cancer screening: knowledge of Pap smear benefits and utilization in Mexico].
    Aguilar-Perez JA; Leyva-López AG; Angulo-Nájera D; Salinas A; Lazcano-Ponce EC
    Rev Saude Publica; 2003 Feb; 37(1):100-6. PubMed ID: 12488926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationships between Self-Efficacy and Pap Smear Screening in Iranian Women.
    Majdfar Z; Khodadost M; Majlesi F; Rahimi A; Shams M; Mohammadi G
    Asian Pac J Cancer Prev; 2016; 17(S3):263-8. PubMed ID: 27165236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coverage and focus of a cervical cancer prevention program in southern Brazil.
    de Quadros CA; Victora CG; da Costa JS
    Rev Panam Salud Publica; 2004 Oct; 16(4):223-32. PubMed ID: 15615596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of hysterectomy on the risk of an abnormal screening Papanicolaou test result.
    Fox J; Remington P; Layde P; Klein G
    Am J Obstet Gynecol; 1999 May; 180(5):1104-9. PubMed ID: 10329862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pap tests for cervical cancer screening test and contraception: analysis of data from the CONSTANCES cohort study.
    Mignot S; Ringa V; Vigoureux S; Zins M; Panjo H; Saulnier PJ; Fritel X
    BMC Cancer; 2019 Apr; 19(1):317. PubMed ID: 30952209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of and attitudes and knowledge about pap smears among women in Kuwait.
    El-Hammasi K; Samir O; Kettaneh S; Al-Fadli A; Thalib L
    J Womens Health (Larchmt); 2009 Nov; 18(11):1825-32. PubMed ID: 19951218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.